GENEVIEVE POTTS: Open Payments
NPI 1689810848 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,891 in 127 payments from 21 companies in 2025. Trend: 2023 $2,519 · 2024 $2,811 · 2025 $2,891
Food & beverage: $2,891
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $527 |
| Amgen Inc. | 34 | $504 |
| Novartis Pharmaceuticals Corporation | 21 | $440 |
| Janssen Biotech, Inc. | 14 | $414 |
| ANI Pharmaceuticals, Inc. | 9 | $197 |
| Mallinckrodt Hospital Products Inc. | 9 | $163 |
| ABBVIE INC. | 1 | $125 |
| Radius Health, Inc. | 6 | $120 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| SOBI, INC | 2 | $55 |
Products named: Bimzelx, COSENTYX, TREMFYA, PURIFIED CORTROPHIN GEL, KRYSTEXXA, ACTHAR, OTEZLA, Tymlos.
Industry payments across TX — which companies pay providers there.
